Clinical Trials Browser

OTHER × aflutinib × 30 days × Clear all

NCT07622706 2026-06-03

Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma

Phase 2 Not yet recruiting

NSCLC